I'm an economist with an active research and teaching program at Harvard, specializing in healthcare and life sciences. My academic research focuses on technology adoption, productivity, and innovation in healthcare — my dissertation examined telemedicine, software innovation in medical devices, and technology-enabled remote work.
In practice, I apply econometrics, causal inference, and large-scale claims data analysis to complex healthcare litigation. My applied work spans pharmaceutical and medical device product liability, False Claims Act matters involving kickbacks, patient assistance programs, and bundled discounts, payor-provider reimbursement disputes including network contract disputes, out-of-network reimbursement, and the 340B program, and antitrust matters related to generic entry, exclusive contracting, pay-for-delay, and drug-device combinations.
Currently, I'm a Senior Managing Economist at Berkeley Research Group, where I lead teams of 10+ analysts and economists across multi-party healthcare engagements. I design, build, and defend complex analytical models subject to adversarial and regulatory scrutiny, and have presented findings to government investigators and counsel.
I teach The Economics of Digitization at Harvard College, where I received a Derek C. Bok Award for Teaching Excellence. I previously taught Health Economics to graduate students at the Harvard T.H. Chan School of Public Health. One of the great joys in my life is teaching, and I've taught continuously at Harvard since 2016
Previously, I was Director of Data and Analytics for Health Affairs at Boston Children's Hospital, where I led enterprise analytics across 11 departments and co-chaired the Data Governance Council. Before that, I was an economist at Analysis Group, where I led teams on causal inference in litigation as well as HEOR and real-world evidence generation for pharmaceutical clients.
I hold a PhD from Harvard Business School and a BA in Economics with High Honors from Dartmouth College. My research affiliations have included the National Bureau of Economic Research under both Amitabh Chandra and Heidi Williams, and the Feinstein Institutes for Medical Research at Northwell Health.
